New pill hopes to fight advanced cancers when other treatments fail

NCT ID NCT07163325

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests an experimental oral drug called EP102 in people with advanced solid tumors who have no other treatment options. The main goals are to find the safest dose and understand side effects. About 48 participants with specific cancer types will take the drug by mouth, and researchers will monitor how the body processes it and whether it shrinks tumors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR (PHASE 1) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cliniques universitaires Saint-Luc

    RECRUITING

    Brussels, 1200, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitari Vall d'Hebron - Vall d'Hebron Institute of Oncology

    RECRUITING

    Barcelona, 8035, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario de Santiago de Compostela

    RECRUITING

    Santiago de Compostela, 15706, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut Jules Bordet

    RECRUITING

    Brussels, 1070, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Leuven Cancer Institute (LKI)

    RECRUITING

    Leuven, 3000, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Masaryk Memorial Cancer Institute

    RECRUITING

    Brno, 656 53, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Netherlands Cancer Institute (NKI)

    RECRUITING

    Amsterdam, 1066 CX, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Olomouc University Hospital

    RECRUITING

    Olomouc, 77900, Czechia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • START Madrid - CIOCC

    RECRUITING

    Madrid, 28050, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Universitair Ziekenhuis Gent (UZ Gent) - Drug Research Unit Gent (DRUG)

    RECRUITING

    Ghent, 9000, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Medical Center Groningen, University of Groningen Department of Medical Oncology

    RECRUITING

    Groningen, 9713 GZ, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.